Video Experimental Relacionado
Updated: Feb 22, 2026
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.7K
Shock Cardiogénico: Evidencia Actual, Perspectivas de las Guías y Resultados
Shashank Shekhar1, Ankit Agrawal2, Hussein Almadhoun3
1University Hospitals Harrington Heart & Vascular Institute, Cleveland, OH.
Journal of cardiothoracic and vascular anesthesia
|February 20, 2026
Resumen
El shock cardiogénico (SC) es una causa importante de muerte hospitalaria, que afecta a 40.000-50.000 personas anualmente. A pesar de los avances, la mortalidad a 30 días sigue siendo alta, lo que pone de manifiesto lagunas críticas en la atención.
Sus antecedentes:
- El shock cardiogénico (SC) es una complicación grave del infarto agudo de miocardio y otras afecciones cardíacas.
- Se asocia con altas tasas de mortalidad intrahospitalaria, que oscilan entre el 30% y el 60% en 30 días.
- A pesar de los avances en el tratamiento, los resultados para los pacientes con SC siguen siendo subóptimos.
Conclusiones:
- El shock cardiogénico continúa siendo un desafío clínico crítico con malos pronósticos.
- Se necesita la estandarización de las definiciones, la estadificación y los protocolos de manejo.
- Se requieren investigaciones adicionales y estrategias de atención optimizadas para mejorar los resultados del SC.
Videos de Conceptos Relacionados
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
970
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
970
01:24Blood Pressure Imbalances and Circulatory Shock
1.7K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.7K
01:29Cardiomyopathy V: Interprofessional Care
506
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
506
01:30Cardiomyopathy II: Dilated Cardiomyopathy
634
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
634
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
550
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
550
01:23Cardiopulmonary Resuscitation III: AED Use
828
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
828